Codexis, Inc., a protein engineering company, announced the signing of a multi-year agreement with Tate & Lyle, a global provider of food ingredients and solutions, for the supply and licensing of novel Codexis performance enzymes used in the manufacture of Tate & Lyle’s TASTEVA® M Stevia Sweetener.
“The collaboration to develop jointly the breakthrough TASTEVA® M process is the second successful food and beverage ingredient process innovation partnership between Tate & Lyle and Codexis,” said John Nicols, Codexis President and Chief Executive Officer. “Each of those projects rapidly progressed from concept to commercializable process and, in fact, partnering on the TASTEVA® M process was initiated just over two years ago (link). We expect over time that our enzymes for TASTEVA® M will become among our leading revenue-producing products in our Performance Enzyme portfolio.”
“The partnership model is a hallmark of speed and innovation for both partners, leveraging the global market and manufacturing reach of Tate & Lyle together with the unique technological capabilities and speed of Codexis,” said Andrew Taylor, Tate & Lyle President of Innovation and Commercial Development. “Initial customer interest in this new, better tasting stevia sweetener has been strong, with some nutrition and bakery products formulated with TASTEVA® M already commercially available.”
Codexis Signs Licensing Agreement with Tate & Lyle
Codexis’ enzyme cascade system enables better-tasting stevia product launch
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
